Levetiracetam
NDC 68180-117, Levetiracetam, tablet, extended release, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 68180-117
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091399
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68180-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM500 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68180-117-07 | 68180011707 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-117-07) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/18648f51-a37c-41e1-b451-123bc0cf5446NADAC price for package 68180011707
GET /v1/drugs/nadac/68180011707
Use it
Look up 68180-117 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68180-117 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68180-117. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.